Last reviewed · How we verify
Compound Nanying zhitong Ointment — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Compound Nanying zhitong Ointment (Compound Nanying zhitong Ointment) — Jiangsu Kanion Pharmaceutical Co., Ltd. Nanying zhitong ointment's mechanism is not publicly available.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Compound Nanying zhitong Ointment TARGET | Compound Nanying zhitong Ointment | Jiangsu Kanion Pharmaceutical Co., Ltd | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Compound Nanying zhitong Ointment CI watch — RSS
- Compound Nanying zhitong Ointment CI watch — Atom
- Compound Nanying zhitong Ointment CI watch — JSON
- Compound Nanying zhitong Ointment alone — RSS
Cite this brief
Drug Landscape (2026). Compound Nanying zhitong Ointment — Competitive Intelligence Brief. https://druglandscape.com/ci/compound-nanying-zhitong-ointment. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab